🇺🇸 FDA
Patent

US 6407108

1,2,4-triazolo(4,3-b)pyrido(3,2-d)pyridazine derivatives and pharmaceutical compositions containing them

expired A61PA61P1/00A61P1/04

Quick answer

US patent 6407108 (1,2,4-triazolo(4,3-b)pyrido(3,2-d)pyridazine derivatives and pharmaceutical compositions containing them) held by Almirall Prodesfarma S.A. expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Almirall Prodesfarma S.A.
Grant date
Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/00, A61P11/06